The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the American Medical Directors Association

• Publication date

  2015-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jamda.2015.03.015PMID 25933724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trials.

  2014cited by this paper
• Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases

  2013cited by this paper
• Prevalence of delirium among outpatients with dementia

  2013cited by this paper
• Articles of interest in other scholarly journals

  2013cited by this paper
• Palliative sedation in end-of-life care and survival: a systematic review.

  2012cited by this paper
• Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review

  2012cited by this paper
• Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: A randomized controlled trial*

  2012cited by this paper
• Trends in antipsychotic use in dementia 1999-2007.

  2011cited by this paper
• GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).

  2011cited by this paper
• GRADE guidelines 6. Rating the quality of evidence--imprecision.

  2011cited by this paper
• Are All Commonly Prescribed Antipsychotics Associated with Greater Mortality in Elderly Male Veterans with Dementia?

  2010cited by this paper
• Chapter 8: Assessing risk of bias in included studies

  2008cited by this paper
• Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

  2008cited by this paper
• Assessing Risk of Bias in Included Studies

  2008cited by this paper
• Risk of Death Associated with Antipsychotic Drug Dispensing in Residential aged Care Facilities

  2007cited by this paper
• Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

  2006cited by this paper
• Haloperidol Prophylaxis for Elderly Hip‐Surgery Patients at Risk for Delirium: A Randomized Placebo‐Controlled Study

  2005cited by this paper
• Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

  2005cited by this paper
• Haloperidol for agitation in dementia.

  2002cited by this paper
• Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

  2002cited by this paper
• Pattern of Drug Use by Advanced Cancer Patients Followed at Home

  2001cited by this paper
• Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment

  2000cited by this paper
• Treatment of agitation in AD

  2000cited by this paper
• Prophylactic Consecutive Administration of Haloperidol Can Reduce the Occurrence of Postoperative Delirium in Gastrointestinal Surgery

  1999cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.

  1998cited by this paper
• Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

  1998cited by this paper
• Prevalence of dementia, delirium and psychiatric symptoms in various care settings for the elderly.

  1998cited by this paper
• Prevalence of dementia, delirium and psychiatric symptoms in various care settings for the elderly

  1998cited by this paper
• Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.

  1997cited by this paper
• Long‐term survival and predictors of mortality in Alzheimer's disease and multi‐infarct dementia

  1995cited by this paper
• A randomized, placebo‐controlled trial of thiothixene in agitated, demented nursing home patients'

  1995cited by this paper
• Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.

  1984cited by this paper
• Efficacy of antipsychotic medications in behaviorally disturbed dementia patients.

  1982cited by this paper
• Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.

  1982cited by this paper
• Thiothixene in the Treatment of Geriatric Patients with Chronic Organic Brain Syndrome *

  1976cited by this paper
• HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE.

  1964cited by this paper
• THE USE OF TRIFLUOPERAZINE IN GERIATRIC PATIENTS WITH CHRONIC BRAIN SYNDROME *

  1962cited by this paper

• Comparative Efficacy and Tolerability of Multiple Antipsychotics Across Varying Doses for Neuropsychiatric Symptoms of Dementia Including Alzheimer's Disease: A Dose–Response Model‐Based Network Meta‐Analysis

  2025cites this paper
• Major adverse cardiac events with haloperidol: A meta-analysis

  2025influential citation
• Preventable or potentially inappropriate psychotropics and adverse health outcomes in older adults: systematic review and meta-analysis

  2024cites this paper
• Antipsychotics in Perspective: Past, Present, and Future (Article 2 of 3).

  2024cites this paper
• Mortality in the Oldest-Old Adults After Discharge From Acute Geriatric Ward

  2023cites this paper
• Olanzapine, Risperidone and Clozapine prescribing is associated with increased risk for Alzheimers Disease reflecting antipsychotic-specific effects on microglial phagocytosis

  2023cites this paper
• Efficacy of tiapride in the treatment of psychiatric disorders: A systematic review

  2022cites this paper
• Should antipsychotics be used for the management of agitation and psychosis in dementia?

  2022cites this paper
• Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

  2021cites this paper
• Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.

  2021cites this paper
• Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets

  2020cites this paper
• Stroke Risk Among Elderly Users of Haloperidol and Typical Antipsychotics Versus Atypical Antipsychotics: A Real-World Study From a US Health Insurance Claims Database.

  2020cites this paper
• Do South African Xhosa-Speaking People with Schizophrenia Really Fare Better?

  2020cites this paper
• Initiation of antipsychotics after moving to residential aged care facilities and mortality: a national cohort study

  2020cites this paper
• Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia

  2020cites this paper
• Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study

  2020cites this paper
• Agents intervening against delirium in the intensive care unit (AID‐ICU) – Protocol for a randomised placebo‐controlled trial of haloperidol in patients with delirium in the ICU

  2019cites this paper
• Associations between the use of specific psychotropic drugs and all-cause mortality among older adults in Germany: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998

  2019cites this paper
• Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study.

  2019cites this paper
• Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis

  2019cites this paper
• Independent discussion sections for improving inferential reproducibility in published research

  2019cites this paper
• Intermittent antipsychotic medication and mortality in institutionalized older adults: A scoping review

  2019cites this paper
• Treatment of Schizophrenia and Psychoses in Older Adults: Psychopharmacological Approaches

  2019cites this paper
• Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with young‐onset dementia

  2019cites this paper
• Cardiovascular effects of psychotic illnesses and antipsychotic therapy

  2019cites this paper
• Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia

  2019cites this paper
• Le syndrome confusionnel chez le patient âgé ayant des troubles neurocognitifs

  2018cites this paper
• Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study

  2018cites this paper
• Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.

  2018cites this paper
• Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials

  2018cites this paper
• Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care

  2018cites this paper
• Gesamtliteraturverzeichnis

  2018cites this paper
• Kapitel 99 – Organisch begründete psychische Erkrankungen am Beispiel des Delirs

  2017cites this paper
• Reforming Management of Behavior Symptoms and Psychiatric Conditions in Long-Term Care Facilities: A Different Perspective.

  2017cites this paper
• Antipsychotics-induced diabetes mellitus in rats: it is time to change

  2017cites this paper
• Antipsychotics, Antidepressants, Anticonvulsants, Melatonin, and Benzodiazepines for Behavioral and Psychological Symptoms of Dementia: a Systematic Review of Meta-analyses

  2017cites this paper
• Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia

  2016cites this paper
• Reply to “Antipsychotics: Mortality Risk Themselves?”

  2016cites this paper
• Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

  2016cites this paper
• A review on mortality risks associated with antipsychotic use in behavioral and psychologic symptoms of dementia (BPSD)

  2016cites this paper
• Detecting and Managing Adverse Effects of Antipsychotic Medications: Current State of Play.

  2016cites this paper
• Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses

  2016influential citation
• Antipsychotics: Mortality Risk Themselves?

  2016cites this paper
• Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients.

  2016cites this paper
• Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan

  2016cites this paper
• The use of low-dose antipsychotic medication

  2016cites this paper
• Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults

  2016cites this paper
• Predictors of Mortality in Dementia: The PRIME Study

  2016cites this paper
• Dysphagia and Aspiration.

  2015cites this paper
• Does antipsychotic drug use increase the risk of long term mortality? A systematic review and meta-analysis of observational studies

  2015cites this paper
• Second-generation-antipsychotic drugs and short-term-mortality: A meta-analysis of placebo-controlled randomized controlled trials

  year unknowncites this paper